Business

TAHO Pharmaceuticals Reports Positive Results from Pivotal Study of TAH3311, the First Oral Dissolving Film Anticoagulant

TAIPEI,Feb. 17,2025-- TAHO Pharmaceuticals announces positive preliminary results from the pivotal study of TAH3311,the world\'s first Apixaban oral dissolving film (ODF). The study confirmed that TAH

02-18

Minish Holds First Seminar in Japan with Great Success - Over 100 Dentists in Attendance

"Impressed by Extensive Full-Mouth Rehabilitation Cases","Anti-Aging Effects Highly Praised"

02-18 Minish Technology Inc.

Reolink Makes Wireless Security Camera Systems Accessible to All Homes

LOS ANGELES,Feb. 17,2025-- Every homeowner deserves peace of mind when it comes to home security. Reolink,an innovative leader in intelligent visual technology for the home,brings the Wireless Securi

02-18 Reolink Innovation Inc.

Duke and Duke-NUS forge new frontiers in climate health research with S$1million funding

The two institutions awarded more than S$1 million to accelerate five promising areas of research collaboration

02-17

Alphamab Oncology Announces the First Patient Dosed in a Phase III Clinical Study for Ovarian Cancer of Anti-HER2 Bispecific ADC JSKN003

SUZHOU,China,Feb. 13,2025-- Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-306) of anti-HER2 bi

02-14

DAAN Biotherapeutics Signs Antibody Exclusive Licensing Agreement with LigaChem Biosciences for ADC (Antibody-Drug Conjugate) Therapeutic Development

SEOUL,South Korea,Feb. 13,2025-- DAAN Biotherapeutics,a leading innovative drug development company specializing in T-cell receptor (TCR)- based therapies,has signed an exclusive licensing agreement w

02-14

Year of the Snake Celebrations Bring Lively Festivities to Cangzhou

CANGZHOU,China,Feb. 13,2025-- A news report from xinhuanet: The Year of the Snake ushers in an energetic Spring Festival in Cangzhou,Hebei Province. Locals and tourists alike are reveling in the festi

02-14

AI is turbocharging media production and democratizing creativity, but challenges persist for the industry, reveals new MIT Technology Review Insights research report

Digital media standards underlie every advance CAMBRIDGE,Mass.,Feb. 13,2025-- A new report byMIT Technology Review Insights explores how emerging tech is remaking the media and entertainment industri

02-14

enreap Earns 2025 Great Place To Work Certification™

PUNE,India,Feb. 13,2025-- enreapis proud to be Certified™ by Great Place To Work® for the third year in a row. The prestigious award is based entirely on what current employees say about their ex

02-14

Restore Vision Announces First Patient Dosed in Phase I/II Clinical Trial of RV-001 for Gene-Agnostic Retinitis Pigmentosa

The first optogenetic "Chimeric Rhodopsin" gene therapy tested in humans. RV-001 starting dose was generally well tolerated in this open-label trial.

02-14 Restore Vision Inc.